ArticleNPJ breast cancer2019

NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients.

Elisa H F Jandrey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.